Reference:
Front Line COVID-19 Critical Care Alliance. (2021). Prevention & treatment protocols for COVID-19. Retrieved from https://flccc.net
Summary:
The Front Line COVID-19 Critical Care Alliance (FLCCC) has established a comprehensive treatment protocol, MATH+, aimed at addressing the severe inflammatory response in COVID-19 patients. This protocol recommends a combination of medications, including methylprednisolone, ascorbic acid, thiamine, and heparin, to mitigate the hyper-inflammatory state and prevent complications such as blood clots. The protocol emphasizes early intervention, recommending that treatment commence as soon as patients exhibit oxygen requirement or abnormal chest X-ray findings. Dosages are carefully outlined, with specific adjustments based on patient response. For instance, methylprednisolone is initially administered as an IV bolus and may be escalated if oxygenation does not improve. The use of ivermectin has also been integrated due to emerging efficacy data. FLCCC advocates for timely hospitalisation to enhance treatment outcomes and reduce the necessity for mechanical ventilation. The organisation continually reviews and updates these protocols as new evidence emerges, aiming to optimise patient care and recovery in hospital settings. The approach underscores the importance of addressing both inflammation and coagulation in managing COVID-19 effectively.